Top Abstract Purchase Related
Home
>
Node
>
Subnode

Prevention of recurrent fetal loss caused by antiphospholipid syndrome

Black, K.D.; Ecker, M.; Librizzi, R.J.

Journal of Perinatology Official Journal of the California Perinatal Association 16(3 Pt 1): 181-185

1996

ISSN/ISBN: 0743-8346
PMID: 8817426
Document Number: 458943
Repeated fetal loss presents a challenge for both patients and health care professionals. Antiphospholipid syndrome (APS) may account for as much as 10% to 48% of recurrent fetal loss. Suggested pathophysiologic mechanisms of APS in fetal loss include the action of autoantibodies, the lupus anticoagulant, and anticardiolipin antibodies on the endothelial cells, which may lead to platelet aggregation, thrombosis, placental infarcts, and subsequently reduced oxygenation to the fetus. This study explores fetal loss caused by APS, its pathophysiologic features, treatment, and nursing implications. Heparin therapy is presented as a method to prevent intrauterine growth retardation and fetal death. The educational and psychosocial needs of patients receiving this therapy and necessary patient follow-up and coordination of services are reviewed.

Document emailed within 1 workday
Secure & encrypted payments

Toyoshima, K.; Makino, T.; Sugi, T.; Sakai, A.; Nozawa, S.; Iizuka, R. 1991: Diagnosis of antiphospholipid syndrome evaluated by the standard serum and its clinical application for recurrent fetal loss Nihon Sanka Fujinka Gakkai Zasshi 43(2): 253-256
Tincani, A.; Cattaneo, R.; Martinelli, M.; Faden, D.; Tarantini, M.; Cerri, V.; Balestrieri, G. 1987: Antiphospholipid antibodies in recurrent fetal loss: only one side of the coin? Clinical and Experimental Rheumatology 5(4): 390-392
Chakrabarti, S.; Bhunia, C.; Bhattacharya, D.K. 1999: The prevalence of antiphospholipid antibodies in cases of recurrent pregnancy loss Journal of the Association of Physicians of India 47(5): 496-498
Vora, S.; Shetty, S.; Salvi, V.; Satoskar, P.; Ghosh, K. 2008: A comprehensive screening analysis of antiphospholipid antibodies in Indian women with fetal loss European Journal of Obstetrics Gynecology and Reproductive Biology 137(2): 136-140
Asherson, R.A.; Thompson, R.P.; MacLachlan, N.; Baguley, E.; Hicks, P.; Hughes, G.R. 1989: Budd Chiari syndrome, visceral arterial occlusions, recurrent fetal loss and the "lupus anticoagulant" in systemic lupus erythematosus Journal of Rheumatology 16(2): 219-224
Clark, C.A.; Spitzer, K.A.; Crowther, M.A.; Nadler, J.N.; Laskin, M.D.; Waks, J.A.; Laskin, C.A. 2007: Incidence of postpartum thrombosis and preterm delivery in women with antiphospholipid antibodies and recurrent pregnancy loss Journal of Rheumatology 34(5): 992-996
Lockshin, M.D. 1999: Pregnancy loss in the antiphospholipid syndrome Thrombosis and Haemostasis 82(2): 641-648
Gris, J.C.; Quéré, I.; Sanmarco, M.; Boutiere, B.; Mercier, E.; Amiral, J.; Hubert, A.M.; Ripart-Neveu, S.; Hoffet, M.; Tailland, M.L.; Rousseau, O.; Monpeyroux, F.; Dauzat, M.; Sampol, J.; Daures, J.P.; Berlan, J.; Marès, P. 2000: Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The Nîmes Obstetricians and Haematologists Study--NOHA Thrombosis and Haemostasis 84(2): 228-236
Skrzypczak, J.; Rajewski, M.; Wirstlein, P.ła.; Goździewicz, T.; Zimmer, M.; Wołczyński, S.ła.; Leszczyńska-Gorzelak, B.; Breborowicz, G.; Ludwikowski, G. 2011: Frequency of antiphospholipid syndrome in women with pregnancy loss in multicenter study in Poland Ginekologia Polska 82(10): 749-754
Salazar-Paramo, M.; Orozco-Barocio, G.; Angles-Cano, E.; Garcia-De La Torre, I. 1995: Acquired protein S deficiency with primary antiphospholipid syndrome and recurrent thrombotic events: report of a case Revue du Rhumatisme 62(11): 810-811
Callot, V.; Sirieix, M.E.; Cohen, P.; Nochy, D.; Jouachim, Y.; Jacquot, C.; Capron, L.; Fiessinger, J.N. 1995: Recurrent leg ulcers, intra-alveolar hemorrhage, perforation of the nasal septum: primary antiphospholipid syndrome? Annales de Medecine Interne 146(5): 366-369
Mastronardi, R.; Presicci, V.; Ciasca, G. 1987: Echographic diagnosis of fetal hydrops and ascites. Description of 2 cases of fetal hydrops and ascites caused by congenital immunodeficiency and feto-fetal transfusion syndrome. Etio-pathogenic considerations Minerva Ginecologica 39(5): 337-341
Alio, A.P.; Nana, P.N.; Salihu, H.M. 2009: Spousal violence and potentially preventable single and recurrent spontaneous fetal loss in an African setting: cross-sectional study Lancet 373(9660): 318-324
Makatsariia, A.D.; Genievskaia, M.G. 2001: Thrombophilia and fetal loss syndrome Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 2001(1): 35-40
Boffa, M.C.; Piette, J.C. 1996: Questions-answers about antiphospholipid-protein antibodies and the "antiphospholipid antibody syndrome" Annales de Medecine Interne 147 Suppl. 1: 54-56
Kühne, C.; Keitel, W.; Flach, W. 1994: Clinical relevance of the antiphospholipid syndrome. Antiphospholipid antibodies in a mixed rheumatologic patient sample Fortschritte der Medizin 112(30): 423-426
Sciascia, S.; Giachino, O.; Roccatello, D. 2012: Prevention of thrombosis relapse in antiphospholipid syndrome patients refractory to conventional therapy using intravenous immunoglobulin Clinical and Experimental Rheumatology 30(3): 409-413
Roujanski, C.; Saveuse, H.; Houbouyan, L.; Lesur, G.; Barre, O.; Dupont, C.; Rouveix, E.; Dorra, M. 1993: Adrenal insufficiency caused by bilateral hemorrhage of the adrenal glands in antiphospholipid syndrome Annales de Medecine Interne 144(1): 72-74
Cicogna, R.; Visioli, O. 1988: A new reflex cardiovascular syndrome: recurrent vasodepressive syncope caused by lesions or tumors of the parapharyngeal space. Etiopathogenesis, clinical picture, differential diagnosis with carotid sinus syndrome and glossopharyngeal neuralgia-asystole syndrome. Therapy by intracranial resection of the 9th cranial nerve Giornale Italiano di Cardiologia 18(5): 361-368
Reich, H. 1976: Thomson's syndrome: prevention of loss of sight Medizinische Klinik 71(49): 2185-2186